| Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study NM Chanzá, W Xie, MA Bilen, H Dzimitrowicz, J Burkart, DM Geynisman, ... The lancet oncology 20 (4), 581-590, 2019 | 164 | 2019 |
| Impact of performance status on treatment outcomes: A real‐world study of advanced urothelial cancer treated with immune checkpoint inhibitors AR Khaki, A Li, LN Diamantopoulos, MA Bilen, V Santos, J Esther, ... Cancer 126 (6), 1208-1216, 2020 | 88 | 2020 |
| Immunotherapy for urothelial carcinoma: current evidence and future directions A Tripathi, ER Plimack Current urology reports 19, 1-10, 2018 | 63 | 2018 |
| A new prognostic model in patients with advanced urothelial carcinoma treated with first-line immune checkpoint inhibitors AR Khaki, A Li, LN Diamantopoulos, NJ Miller, L Carril-Ajuria, ... European urology oncology 4 (3), 464-472, 2021 | 53 | 2021 |
| Histological subtypes and response to PD-1/PD-L1 blockade in advanced urothelial cancer: a retrospective study NJ Miller, AR Khaki, LN Diamantopoulos, MA Bilen, V Santos, N Agarwal, ... The Journal of urology 204 (1), 63-70, 2020 | 47 | 2020 |
| Androgen receptor in bladder cancer: A promising therapeutic target A Tripathi, S Gupta Asian Journal of Urology 7 (3), 284-290, 2020 | 41 | 2020 |
| Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer A Hussain, A Tripathi, C Pieczonka, D Cope, A McNatty, C Logothetis, ... Prostate cancer and prostatic diseases 24 (2), 290-300, 2021 | 30 | 2021 |
| Mitoxantrone‐Induced Cardiotoxicity in Acute Myeloid Leukemia—A Velocity Vector Imaging Analysis AY Shaikh, S Suryadevara, A Tripathi, M Ahmed, JL Kane, J Escobar, ... Echocardiography 33 (8), 1166-1177, 2016 | 30 | 2016 |
| PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer VS Koshkin, VG Patel, A Ali, MA Bilen, D Ravindranathan, JJ Park, ... Prostate cancer and prostatic diseases 25 (3), 388-396, 2022 | 29 | 2022 |
| Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma A Tripathi, E Lin, W Xie, A Flaifel, JA Steinharter, ENS Gatof, G Bouchard, ... Journal for immunotherapy of cancer 8 (2), 2020 | 27 | 2020 |
| The impact of statin use on the efficacy of abiraterone acetate in patients with castration‐resistant prostate cancer LC Harshman, L Werner, A Tripathi, X Wang, BL Maughan, ... The Prostate 77 (13), 1303-1311, 2017 | 27 | 2017 |
| Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study NM Chanza, W Xie, M Issa, H Dzimitrowicz, A Tripathi, B Beuselinck, ... Journal for immunotherapy of cancer 8 (1), 2020 | 26 | 2020 |
| Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes SM Esagian, AR Khaki, LN Diamantopoulos, L Carril‐Ajuria, D Castellano, ... BJU international 128 (2), 196-205, 2021 | 24 | 2021 |
| INTACT (S/N1806) phase III randomized trial of concurrent chemoradiotherapy with or without atezolizumab in localized muscle-invasive bladder cancer: Safety update on first 73 … P Singh, JA Efstathiou, C Tangen, SG Jhavar, NM Hahn, BA Costello, ... Journal of Clinical Oncology 39 (6_suppl), 428-428, 2021 | 23 | 2021 |
| Adjuvant therapy options in renal cell carcinoma: where do we stand? N Martinez Chanza, A Tripathi, LC Harshman Current treatment options in oncology 20, 1-16, 2019 | 23 | 2019 |
| The utility of next generation sequencing in advanced urothelial carcinoma A Tripathi, P Grivas European Urology Focus 6 (1), 41-44, 2020 | 21 | 2020 |
| Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial H Ebrahimi, N Dizman, L Meza, J Malhotra, X Li, T Dorff, P Frankel, ... Nature Medicine 30 (9), 2576-2585, 2024 | 19 | 2024 |
| Adjuvant pembrolizumab versus observation in muscle-invasive urothelial carcinoma AB Apolo, KV Ballman, G Sonpavde, S Berg, WY Kim, R Parikh, MY Teo, ... New England Journal of Medicine 392 (1), 45-55, 2025 | 18 | 2025 |
| Contemporary patterns of multidisciplinary care in patients with muscle-invasive bladder cancer LC Harshman, A Tripathi, M Kaag, JA Efstathiou, AB Apolo, ... Clinical genitourinary cancer 16 (3), 213-218, 2018 | 18 | 2018 |
| PARP inhibitors in castration-resistant prostate cancer A Tripathi, P Balakrishna, N Agarwal Cancer Treatment and Research Communications 24, 100199, 2020 | 17 | 2020 |